U.S. market Closed. Opens in 17 hours 8 minutes

LIFE | aTyr Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue353.00K10.39MN/A10.46M422.00KN/AN/AN/AN/AN/AN/A
Cost of Revenue2.74M1.70M1.30M17.29M14.05MN/AN/AN/AN/AN/AN/A
Gross Profit-2.39M8.69M-1.30M-6.84M-13.63MN/AN/AN/AN/AN/AN/A
Operating Expenses52.53M56.79M34.02M26.37M23.40M32.82M47.15M57.94M47.62MN/AN/A
Selling, General & Admin10.24M13.98M10.75M9.07M9.35M12.44M17.08M15.09M13.11M6.78M5.71M
Research & Development42.29M42.81M23.26M17.29M14.05M20.39M30.07M42.85M34.50M16.78M13.83M
Other Operating Expenses4.52M1.06M238.00K-319.00K-785.00K-1.70MN/AN/AN/AN/AN/A
Operating Income-54.92M-46.40M-34.02M-15.91M-22.98M-32.82M-47.15M-57.94M-47.62M-23.55M-19.54M
Other Expenses / Income4.52M1.06M238.00K-319.00K-785.00K-1.70M-1.06M36.00K-357.00K-796.00K-472.00K
Before Tax Income-50.40M-45.34M-33.78M-16.23M-23.76M-34.52M-48.21M-57.90M-47.97M-24.35M-20.01M
Income Tax Expenses-8.00K-1.07M-1.31M-1.27M-1.53M-1.70MN/A-49.00KN/AN/AN/A
Net Income-50.39M-44.28M-32.46M-14.96M-22.24M-34.52M-48.21M-57.85M-47.97M-24.35M-20.01M
Interest ExpensesN/A-1.70MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding53.61M28.42M19.08M9.16M3.36M2.14M1.84M1.69M1.13M719.51K719.51K
Diluted Shares Outstanding53.61M28.42M19.08M9.16M3.36M2.14M1.84M1.69M1.13M719.51K719.51K
EBITDA-52.18M-46.40M-34.02M-15.91M-22.98M-32.82M-47.49M-57.04M-46.75M-22.76M-18.80M
EBITDA Margin-14,781.30%-446.79%0.00%-152.19%-5,445.02%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-50.40M-47.04M-33.78M-16.23M-23.76M-36.21M-48.21M-57.90M-47.97M-24.35M-20.01M
EBIT Margin-14,276.77%-452.90%0.00%-155.24%-5,631.04%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙